You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
锦欣生殖(01951.HK)公开发售超购约99.26倍预期6月25日上市
格隆汇 06-24 06:23

格隆汇6月24日丨锦欣生殖(01951.HK)公布,全球发售约3.57亿股,其中香港发售1.43亿股,国际发售2.14亿股;发售价每股8.54港元;每手2,000股;2019年6月25日上市。

公告显示,香港公开发售获大幅超额认购,相等于根据香港公开发售初步可供认购香港发售股份总数约99.26倍。

国际发售方面,获大幅超额认购,发售股份相当于全球发售项下的发售股份总数约60%(于任何超额配股权获行使前)。

据悉,基石投资者认购的发售股份总数约为1.38亿股发售股份,相当于根据全球发售提呈发售的发售股份数目约38.56%或公司紧随全球发售完成后的已发行股本总额约5.78%(假设超额配股权并无获行使)。

公告称,所得款项净额约为28.08亿港元。其中,约25.0%用于扩建及升级位于中国网络的辅助生殖医疗机构及招募医疗专业人员;约20.0%用于潜在收购位于目前并无业务的中国省份的额外辅助生殖医疗机构。约10.0%用于投资研发;约20.0%用于潜在收购辅助生殖服务服务提供商及沿辅助生殖服务服务链的业务;约15.0%用于提高在中国及美国的品牌知名度;约10.0%用于营运资金及用于一般公司用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account